MODI’IN, Israel and MANASQUAN, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and ...
Exalenz Bioscience is collaborating with the Acute Liver Failure Study Group. 1. Exalenz Bioscience and the Acute Liver Failure Study Group will study the ability of the BreathID Methacetin Breath ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results